The Ultimate Resource for Pharmaceutical SOPs and Best Practices
The purpose of this SOP is to outline the procedure for designing extended-release (ER) capsule formulations. The aim is to develop capsules that provide a controlled release of the active pharmaceutical ingredient (API) over an extended period, ensuring that the drug is released gradually and consistently for optimal therapeutic effects.
Click to read the full article.
The purpose of this SOP is to establish a consistent procedure for formulating high-potency drugs in capsules. High-potency drugs require special handling and formulation techniques due to their small therapeutic dose and potential risk to personnel during production.
Click to read the full article.
The purpose of this SOP is to establish a systematic approach for validating capsule development procedures. It ensures that all processes related to capsule formulation, filling, and sealing are performed under controlled conditions and meet regulatory and quality standards.
Click to read the full article.
The purpose of this SOP is to define the procedure for conducting shelf-life prediction studies for capsules. These studies are critical in determining the stability and expiry date of capsules, ensuring their effectiveness, safety, and compliance with regulatory standards over time.
Click to read the full article.
The purpose of this SOP is to define the procedures for preparing technical dossiers for capsules. These dossiers are essential for regulatory submissions, ensuring that capsules meet the necessary safety, efficacy, and quality standards as required by authorities such as the FDA, EMA, and other global regulatory bodies.
Click to read the full article.
The purpose of this SOP is to establish a systematic approach for ensuring regulatory compliance throughout the product development lifecycle of capsules. It aims to ensure that all development activities meet the relevant regulatory requirements to ensure the safety, efficacy, and quality of the product.
Click to read the full article.
The purpose of this SOP is to establish procedures for handling and documenting development trials in the capsule manufacturing process. It ensures that trials are conducted according to approved protocols and are properly documented to maintain product integrity and facilitate regulatory compliance.
Click to read the full article.
The purpose of this SOP is to define the procedures for formulating nutraceutical capsules. This includes guidelines for selecting raw materials, formulation design, manufacturing processes, and quality control to ensure the final product is safe, effective, and compliant with regulatory requirements.
Click to read the full article.
The purpose of this SOP is to outline the procedure for preparing a gelatin solution used in the formulation of capsule shells. This procedure ensures the proper concentration, consistency, and quality of the gelatin solution, which is crucial for the shell formation process.
Click to read the full article.
The purpose of this SOP is to outline the procedure for mixing and blending Active Pharmaceutical Ingredients (APIs) with excipients in capsule formulation. Proper mixing and blending are crucial to ensure uniformity, consistency, and the desired efficacy of the final product.
Click to read the full article.